Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 6
Submit an article Journal homepage
306
Views
33
CrossRef citations to date
0
Altmetric
Research Article

IL-4 Biology: Impact on Normal and Leukemic CLL B Cells

Neil E. Kay Division of Hematology, Department of Medicine, Mayo Graduate and Medical Schools, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905, USA
&
Brian T. Pittner Department of Immunology Mayo Graduate and Medical Schools, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905, USA
Pages 897-903 | Published online: 01 Jul 2009

  • Dameshek, W. (1967) "Chronic lymphocytic leukemia--an accumulative disease of immunolgically incompetent lymphocytes", Blood 29(Suppl), 566-584.
  • Collins, R.J., Verschuer, L.A., Harmon, B.V., Prentice, R.L., Pope, J.H. and Kerr, J.F. (1989) "Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro", Br. J. Haematol. 71, 343-350.
  • Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C. and Binet, J.L. (1991) "B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL", Blood, 1901-1914.
  • Mainou-Fowler, T., Copplestone, J. and Prentice, A. (1995) "Effect of interleukins on the proliferation and survivol of B cell chronic lymphocytic leukaemia cells", J. Clin. Pathol. 48, 482-487.
  • Jewell, A.P., Worman, C.P., Lydyard, P.M., Yong, K.L., Giles, F.J. and Goldstone, A.H. (1994) "Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo", Br. J. Haematol. 88, 268-274.
  • Chaouchi, N., Wallon, C., Taieb, J., Auffredou, M.T., Tertian, G., Lemoine, F.M., Delfraissy, J.F. and Vazquez, A. (1994) "Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc", Clin. Immunol. Immunopathol. 73, 197-204.
  • Buschle, M., Campana, D., Carding, S.R., Richard, C., Hoffbrand, A.V. and Brenner, M.K. (1993) "Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia", J. Exp. Med. 177, 213-218.
  • Huang, R.W., Tsuda, H. and Takatsuki, K. (1993) "Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells", Int. J. Hematol. 58, 83-92.
  • Dancescu, M., Rubio-Trujillo, M., Biron, G., Bron, D., Delespesse, G. and Sarfati, M. (1992) "Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression", J. Exp. Med. 176, 1319-1326.
  • Mu, X., Kay, N.E., Gosland, M.P. and Jennings, C.D. (1997) "Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells", Br. J. Haematol. 96, 733-735.
  • de Totero, D., Reato, G., Mauro, F., Cignetti, A., Ferrini, S., Guarini, A., Gobbi, M., Grossi, C.E. and Foa, R. (1999) "IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukemia", Br. J. Haematol. 104, 589-599.
  • Mainou-Fowler, T., Proctor, S.J., Miller, S. and Dickinson, A.M. (2001) "Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia", Leuk. Lymphoma 42, 689-698.
  • Kay, N.E., Han, L., Bone, N. and Williams, G. (2001) "Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis", Br. J. Haematol. 112, 760-767.
  • Seder, R.A., Paul, W.E., Davis, M.M. and Fazekas de St Groth, B. (1992) "The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice", J. Exp. Med. 176, 1091-1098.
  • Weiss, D.L. and Brown, M.A. (2001) "Regulation of IL-4 production in mast cells: a paradigm for cell-type-specific gene expression", Immunol. Rev. 179, 35-47.
  • Rao, A., Luo, C. and Hogan, P.G. (1997) "Transcription factors of the NFAT family: regulation and function", Annu. Rev. Immunol. 15, 707-747.
  • Kaplan, M.H., Schindler, U., Smiley, S.T. and Grusby, M.J. (1996) "Stat6 is required for mediating responses to IL-4 and for development of Th2 cells", Immunity 4, 313-319.
  • Ranganath, S., Ouyang, W., Bhattarcharya, D., Sha, W.C., Grupe, A., Peltz, G. and Murphy, K.M. (1998) "GATA-3-dependent enhancer activity in IL-4 gene regulation", J. Immunol. 161, 3822-3826.
  • Kim, J.I., Ho, I.C., Grusby, M.J. and Glimcher, L.H. (1999) "The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines", Immunity 10, 745-751.
  • Debinski, W., Minter, R., Leland, P., Obiri, N.I. and Puri, R.K. (1996) "Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells", J. Biol. Chem. 271, 22428-22433.
  • Kawakami, K., Kawakami, M. and Puri, R.K. (2001) "Over-expressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy", Crit. Rev. Immunol 21, 299-310.
  • Kay, N.E., Bone, N.D., Jelinek, D.F., Leland, P., Frank, D.A., Battle, T.E. and Puri, R.K. (2002) Plasma Membrane IL-4 Receptors Can be Targeted to Eliminate B-Chronic Lymphocytic Leukemia B Cells (Abstract 2324) (American Society of Hematology, Philadelphia, PA).
  • Nelms, K., Keegan, A.D., Zamorano, J., Ryan, J.J. and Paul, W.E. (1999) "The IL-4 receptor: signaling mechanisms and biologic functions", Annu. Rev. Immunol. 17, 701- 738.
  • Izuhara, K., Feldman, R.A., Greer, P. and Harada, N. (1994) "Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor", J. Biol. Chem. 269, 18623-18629.
  • Wang, L.M., Myers, Jr., M.G., Sun, X.J., Aaronson, S.A., White, M. and Pierce, J.H. (1993) "IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells", Science 261, 1591-1594.
  • Sun, X.J., Wang, L.M., Zhang, Y., Yenush, L., Myers, Jr., M.G., Glasheen, E., Lane, W.S., Pierce, J.H. and White, M.F. (1995) "Role of IRS-2 in insulin and cytokine signalling", Nature 377, 173-177.
  • Patel, B.K., Pierce, J.H. and LaRochelle, W.J. (1998) "Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6", Proc. Natl Acad. Sci. USA 95, 172-177.
  • Ryan, J.J., McReynolds, L.J., Keegan, A., Wang, L.H., Garfein, E., Rothman, P., Nelms, K. and Paul, W.E. (1996) "Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor", Immunity 4, 123-132.
  • Noellae, R., Krammer, P.H., Ohara, J., Uhr, J.W. and Vitetta, E.S. (1984) "Increased expression of la antigens on resting B cells: an additional role for B-cell growth factor", Proc. Natl Acad. Sci. USA 81, 6149-6153.
  • Vitetta, E.S., Ohara, J., Myers, C.D., Layton, J.E., Krammer, P.H. and Paul, W.E. (1985) "Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgGI", J. Exp. Med. 162, 1726-1731.
  • Defrance, T., Vanbervliet, B., Aubry, J.P., Takebe, Y., Arai, N., Miyajima, A., Yokote, T., Lee, F., Arai, K. and de Vries, J.E. (1987) "B cell growth-promoting activity of recombinant human interleukin 4", J. Immunol. 139, 1135-1141.
  • Clark, E.A., Shu, G.L., Luscher, B., Draves, K.E., Banchereau, J., Ledbetter, J.A. and Valentine, M.A. (1989) "Activation of human B cells. Comparison of the signal transduced by IL-4 to four different competence signals", J. Immunol. 143, 3873-3880.
  • Jelinek, D.F. and Lipsky, P.E. (1988) "Inhibitory influence of IL-4 on human B cell responsiveness", J. Immunol. 141, 164-173.
  • Illera, V.A., Perandones, C.E., Stunz, L.L., Mower, Jr. D.A. and Ashman, R.F. (1993) "Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4", J. Immunol. 151, 2965-2973.
  • Parry, S.L., Hasbold, J., Holman, M. and Klaus, G.G. (1994) "Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40", J. Immunol. 152, 2821-2829.
  • Minshall, C., Arkins, S., Freund, G.G. and Kelley, K.W. (1996) "Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survivol factor", J. Immunol. 156, 939-947.
  • Minshall, C., Arkins, S., Straza, J., Conners, J., Dantzer, R., Freund, G.G. and Kelley, K.W. (1997) "IL-4 and insulin-like growth factor-1 inhibit the decline in Bcl-2 and promote the survivol of IL-3-deprived myeloid progenitors", J. Immunol. 159, 1225-1232.
  • Aronica, M.A., Goenka, S. and Boothby, M. (2000) "IL-4-dependent induction of BCL-2 and BCL-X1 in activated T lymphocytes through a STAT6- and PI 3-kinase-independent pathway", Cytokine 12, 578-587.
  • Minshall, C., Arkins, S., Dantzer, R., Freund, G.G. and Kelley, K.W. (1999) "Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors", J. Immunol. 162, 4542-4549.
  • Panayiotidis, P., Ganeshaguru, K., Jabbar, S.A. and Hoftbrand, A.V. (1993) "Interleokin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro", Br. J. Haematol. 85, 439-445.
  • Bernal, A., Pastore, R.D., Asgary, Z., Keller, S.A., Cesarman, E., Liou, H.C. and Schattner, E.J. (2001) "Survival of leukemic B cells promoted by engagement of the antigen receptor", Blood 98, 3050-3057.
  • Siegel, R.M., Chan, F.K., Chun, H.J. and Lenardo, M.J. (2000) "The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity", Nat. Immunol. 1, 469-474.
  • Foote, L.C., Howard, R.G., Marshak-Rothstein, A. and Rothstein, T.L. (1996) "IL-4 induces Fas resistance in B cells", J. Immunol. 157, 2749-2753.
  • Williams, J.F., Petrus, M.J., Wright, J.A., Husebekk, A., Fellowes, V., Read, E.J., Gress, R.E. and Fowler, D.H. (1999) "Fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type 1 versus type II cytokines and autologous fasL-expressing T cells", Br. J. Haematol. 107, 99-105.
  • Mainou-Fowler, T., Miller, S., Proctor, S.J. and Dickinson, A.M. (2001) "The levels of TNFA, IL-4 and IL-10 production by T cells in B-cell chronic lymphocytic leukemia (B-CLL)", Leuk. Res. 25, 157-163
  • Gajewski, T.F., Pinnas, M., Wong, T. and Fitch, F.W. (1991) "Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations", J. Immunol. 146, 1750-1758
  • Douglas, R.S., Capocasale, R.J., Lamb, R.J., Nowell, P.C. and Moore, J.S. (1997) "Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta", Blood 89, 941-947.
  • Nakanishi, K., Matsui, K., Kashiwamura, S., Nishioka, Y., Nomura, J., Nishimura, Y., Sakaguchi, N., Yonehara, S., Higashino, K. and Shinka, S. (1996) "IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation", Int. Immunol. 8, 791-798.
  • Barragan, M., Bellosillo, B., Campas, C., Colomer, D., Pons, G. and Oil, J. (2002) "Involvement of protein kinase C and phosphatidyl-inositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells", Blood 99, 2969-2976.
  • Luodin, J., Kimby, E., Bergmann, L., Karakas, T., Mellstedt, H. and Osterborg, A. (2001) "Interleukin 4 therapy for patients with chronic lymphocytic leukaemia: a phase I/II study", Br. J. Haematal. 112, 155-160.
  • Chaouchi, N., Wallon, C., Goujard, C., Tertian, G., Rudent, A., Caput, D., Ferrera, P., Minty, A., Vazquez, A. and Delfraissy, J.F. (1996) "Interteukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis", Blood 87, 1022-1029.
  • Henderson, Jr., W.R., Chi, E.Y. and Maliszewski, C.R. (2000) "Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma", J. Immunol. 164, 1086-1095.
  • Kawakami, K., Kawakami, M., Husain, S.R. and Puri, R.K. (2002) 'Targeting interleukin-4 receptors for effective pancreatic cancer therapy", Cancer Res. 62, 3575-3580.
  • Joshi, B.H., Leland, P., Silber, J., Kreitman, R.J., Pastan, I., Berger, M. and Puri, R.K. (2002) "IL-4 receptors on human medullo-blastoma tumours serve as a sensitive target for a circular permuted IL-4-Pseudomonas exotoxin fusion protein", Br. J. Cancer 86, 285-291.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.